These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9818695)

  • 21. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
    Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
    Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver.
    Remberger M; Ringdén O
    Eur J Haematol; 1997 Oct; 59(4):254-62. PubMed ID: 9338624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Veno-occlusive disease of the liver].
    Rybicka M; Krysiak R; Okopień B
    Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased lung uptake of 99Tcm-sulphur colloid as an early indicator of the development of hepatic veno-occlusive disease in bone marrow transplant patients.
    Jacobson AF; Teefey SA; Higano CA; Bianco JA
    Nucl Med Commun; 1993 Aug; 14(8):706-11. PubMed ID: 8371897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation].
    Morio S; Oh H; Kogure K; Ishii H; Ishii A; Nakaseko C; Ikegami T; Kawano E; Matsuura Y; Nishimura M
    Rinsho Ketsueki; 1994 Sep; 35(9):846-52. PubMed ID: 7967053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation.
    Iguchi A; Kobayashi R; Yoshida M; Kobayashi K; Matsuo K; Kitajima I; Maruyama I
    Bone Marrow Transplant; 2001 Jun; 27(11):1173-80. PubMed ID: 11551028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study.
    Tanikawa S; Mori S; Ohhashi K; Akiyama H; Sasaki T; Kaku H; Hiruma K; Matsunaga T; Morita T; Sakamaki H
    Bone Marrow Transplant; 2000 Oct; 26(8):881-6. PubMed ID: 11081389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation.
    Gluckman E; Jolivet I; Scrobohaci ML; Devergie A; Traineau R; Bourdeau-Espérou H; Lehn P; Faure P; Drouet L
    Nouv Rev Fr Hematol (1978); 1990; 32(1):1-3. PubMed ID: 2349075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin.
    Chang FY; Singh N; Gayowski T; Wagener MM; Mietzner SM; Stout JE; Marino IR
    Transplantation; 2000 Jan; 69(1):70-5. PubMed ID: 10653383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.
    Rapoport AP; Doyle HR; Starzl T; Rowe JM; Doeblin T; DiPersio JF
    Bone Marrow Transplant; 1991 Nov; 8(5):421-4. PubMed ID: 1768978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation.
    Morio S; Oh H; Hirasawa A; Aotsuka N; Nakamura H; Asai T; Yoshida S; Ito M
    Bone Marrow Transplant; 1991 Aug; 8(2):147-9. PubMed ID: 1933057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombopoietin in acute liver failure.
    Schiødt FV; Balko J; Schilsky M; Harrison ME; Thornton A; Lee WM;
    Hepatology; 2003 Mar; 37(3):558-61. PubMed ID: 12601353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers.
    Scrobohaci ML; Drouet L; Monem-Mansi A; Devergie A; Baudin B; D'Agay MF; Gluckman E
    Thromb Res; 1991 Sep; 63(5):509-19. PubMed ID: 1755004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.
    Sullivan KM; Kansu E; Storer B; Jocom J; Emerson G; Reagan T; Emerson V; Siadak MF; Davis C; Appelbaum FR; Buckner CD; Hansen JA; Shulman HM; Storb R; McDonald GB
    Biol Blood Marrow Transplant; 1998; 4(1):20-6. PubMed ID: 9701388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation.
    Marsa-Vila L; Gorin NC; Laporte JP; Labopin M; Dupuy-Montbrun MC; Fouillard L; Isnard F; Najman A
    Eur J Haematol; 1991 Nov; 47(5):346-54. PubMed ID: 1761121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma.
    Okubo M; Shiota G; Kawasaki H
    Clin Sci (Lond); 2000 Sep; 99(3):207-14. PubMed ID: 11787473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation.
    Lee JH; Choi SJ; Lee JH; Kim SE; Park CJ; Chi HS; Lee MS; Lee JS; Kim WK; Lee KH
    Ann Hematol; 2005 May; 84(5):321-30. PubMed ID: 15580502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation.
    Matute-Bello G; McDonald GD; Hinds MS; Schoch HG; Crawford SW
    Bone Marrow Transplant; 1998 Jun; 21(11):1125-30. PubMed ID: 9645575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma brain natriuretic peptide is associated with hepatic veno-occlusive disease and early mortality after allogeneic hematopoietic stem cell transplantation.
    Kataoka K; Nannya Y; Iwata H; Seo S; Kumano K; Takahashi T; Nagai R; Kurokawa M
    Bone Marrow Transplant; 2010 Nov; 45(11):1631-7. PubMed ID: 20173786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.